mechanism

alpha_synuclein_aggregation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about alpha_synuclein_aggregation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

52Connections
5Hypotheses
8Analyses
19Outgoing
33Incoming
0Experiments
13Debates

Summary

A mechanism referenced in 4 knowledge graph relationships. Key connections: causes dopaminergic_neuron_death (mechanism); glucosylceramide_accumulation (mechanism) promotes; inhibits GCase (protein).

View on Wiki →

No AI portrait yet

Mechanism Info
Namealpha_synuclein_aggregation
Key Genes/ProteinsALOX15, APOE4, Csga, C-terminal truncations, curli, GCase
Related Diseasesalzheimers, Enteric Nervous System dysfunction, fibril elongation, GlcCer accumulation, gut motility disruption
Related Pathwaysglymphatic_clearance, lactate production

Pathway Diagram

flowchart TD
    N0["Alpha-Synuclein Aggregation"]
    N1["Parkinson's Disease"]
    N0 -->|"causes"| N1
    N2["Mitochondrial Depolarization"]
    N0 -->|"causes"| N2
    N3["Dopaminergic Neurons"]
    N0 -->|"causes"| N3
    N4["ATP Production"]
    N0 -.->|"downregulates"| N4
    N5["Autophagy-Lysosomal Pathway"]
    N0 -->|"involved in"| N5
    N6["Short-Chain Fatty Acids"]
    N6 -->|"modulates"| N0
    N7["Piperine"]
    N7 -.->|"inhibits"| N0
    N8["D-520"]
    N8 -.->|"suppresses"| N0
    N9["Mitochondrial Fragmentation"]
    N0 -->|"causes"| N9
    N10["Neurodegeneration"]
    N0 -->|"causes"| N10
    N11["CNS Inflammation"]
    N0 -->|"causes"| N11
    N12["BMAL1"]
    N12 -.->|"inhibits"| N0
    N13["ceftriaxone"]
    N13 -.->|"inhibits"| N0
    N14["SNCA"]
    N14 -->|"regulates"| N0
    N15["Polyamines"]
    N15 -->|"modulates"| N0

    classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
    classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
    classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
    classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
    classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
    classDef therapeutic fill:#1a2a2a,stroke:#26a69a,color:#e0e0e0
    class N1 disease
    class N5 pathway
    class N12 gene
    class N14 gene

Outgoing (19)

TargetRelationTypeStr
Parkinson's_diseasecausesdisease0.90
mitochondrial_dysfunctioncorrelates_withmechanism0.90
neurodegenerationcausesdisease0.90
Parkinson's diseasecontributes_tounknown0.90
Parkinson's diseasecausesunknown0.90

Incoming (33)

SourceRelationTypeStr
GCasecontributes_toprotein0.95
GCaseinvolved_inprotein0.95
Parkinson's diseaseassociated_withunknown0.95
GCaseinteracts_withprotein0.95
GlcCer accumulationcausesphenotype0.90

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
m6A-dependent control of alpha-synuclein transcript fate and 0.626 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Cell-state stratification is required to resolve m6A RNA Mod 0.612 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration m6A RNA Modification and Alpha-Synuclein
Glucosylceramide accumulation nucleates alpha-synuclein aggr 0.525 parkinsons GBA-Synuclein Loop Therapeutics for PD
Prevotellaceae Metabolite Depletion as Alpha-Synuclein Aggre 0.000 - Does reduced Prevotellaceae abundance ca

Mentioning Analyses (8)

Scientific analyses that reference this entity

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.571

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.703

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-syn

neurodegeneration | 2026-04-12 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (13)

Multi-agent debates referencing this entity

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

Can computational de novo protein binder design produce stable binders that bloc

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The debate identified systemic toxicity as a major concern for glucosylceramide

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate proposed temporal TFEB modulation but identified no validated biomark

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

Can computationally designed binders against alpha-synuclein realistically trans

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning alpha_synuclein_aggregation in their description or question text

No additional research found